Counterfeit Botox and Fillers: How to Verify Authorized Supply

Counterfeit and gray-market Botox and dermal fillers reach US practices mainly through unlicensed sellers offering deep discounts. The protection is simple to describe and takes discipline to run: buy prescription toxins only from the manufacturer or its authorized distributors, verify every supplier's license, inspect every delivery against the manufacturer's authentic packaging features, and log lot numbers so you can act fast on an alert.

This guide covers what regulators have actually found, what federal law requires when you buy, a step-by-step supplier verification process, a receiving inspection checklist, and what to do if you think you have suspect product.

What counts as counterfeit, gray-market or unapproved product?#

These terms get used loosely. It helps to separate them, because the risks and the fixes differ.

For a practice, all four lead to the same place: you may be injecting a product whose identity, potency, sterility and storage history nobody in the US supply chain can vouch for.

What have FDA and CDC actually found?#

Counterfeit toxin is not a hypothetical risk. Here is what federal agencies have documented, in their own words:

Two patterns repeat. First, the product came from unlicensed or unauthorized sources, not from the manufacturer or its authorized distributors. Second, several incidents involved licensed practices buying for use in their own clinics. In the 2024 CDC investigation, the affected patients reported being injected by unlicensed or untrained individuals or in non-healthcare settings, but the earlier FDA letter campaigns went to medical practices. Being a legitimate clinic does not protect you if your supplier is not legitimate.

Why are toxins and fillers such attractive targets?#

You don't need a statistic to see the incentive. Neurotoxins and fillers are high-value, low-volume products that ship in small packages. Practices face real margin pressure on them. And patients can't tell a genuine vial from a fake one; they rely entirely on your sourcing.

That combination makes "same product, lower price" offers tempting. FDA's own Know Your Source flyer puts it plainly: aggressive marketing and deep discounts on prescription drugs "may indicate that the products are stolen, counterfeit, substandard, or unapproved."

The better answer to price pressure is to lower your costs through legitimate channels: comparing authorized offers, consolidating orders and using manufacturer programs. Our medspa supply buying guide walks through how.

What does federal law require when a medspa buys Botox?#

Short answer: practices that administer prescription drugs must buy them only from authorized trading partners. That requirement comes from the Drug Supply Chain Security Act (DSCSA), enacted in 2013 to build an electronic, package-level system to trace prescription drugs through the US supply chain.

Key points for an aesthetic practice:

• You are likely a "dispenser." The statute defines a dispenser to include "any other person authorized by law to dispense or administer prescription drugs" (21 U.S.C. § 360eee). Botulinum toxins are prescription drugs.
• Your suppliers must be authorized. For wholesale distributors, "authorized" means holding a valid state license (or federal license where applicable) and meeting FDA's licensure reporting requirements. FDA's Know Your Source page adds a blunt warning: if you buy drugs from illegal sources, you may be breaking the law.
• Packages carry a product identifier. Under the DSCSA, covered drug packages carry a standardized identifier with the product's numerical identifier, lot number and expiration date in human-readable and machine-readable form.
• Illegitimate product must be reported. Manufacturers, repackagers, wholesale distributors and dispensers must notify FDA within 24 hours after determining a product is illegitimate, using Form FDA 3911.
• Some deadlines are phased. FDA granted small dispensers exemptions from certain requirements through November 27, 2026. Check FDA's DSCSA page for which obligations apply to you and when.

Do the same rules apply to dermal fillers?#

No. Dermal fillers are regulated as medical devices, and the DSCSA's definition of "product" covers prescription drugs, not devices. That doesn't make fillers low-risk to source. FDA tells consumers and providers "do not purchase dermal filler products online" because they could be counterfeit or not approved for the US, and it urges providers to carefully inspect all filler packages for authenticity.

FDA has also warned providers not to use Juvederm Ultra 2, 3 or 4, which are sold in other markets but are not approved for use in the US. If you see these names on a US price list, treat it as a red flag.

State pharmacy and medical boards may add their own requirements on top of federal law. Check with your state board and your healthcare attorney.

How do you verify that a supplier is authorized?#

Run this check before your first order with any new source of toxins or fillers, and repeat it at least once a year.

1. Ask the manufacturer. For branded toxins, the manufacturer is the final word on who is authorized. In 2015, FDA told practitioners to "check with Allergan to make sure that the distributor that they purchase from is authorized to distribute Botox." Allergan Aesthetics says it is the only authorized supplier of Botox in the US and that licensed providers buy directly from it; its authenticity line is (800) 255-5162. Other manufacturers can tell you whether they sell direct, through named distributors, or both.
2. Check the state license. FDA recommends checking the licensing website of the state where the distributor does business to confirm it has a valid wholesale drug distributor license. Also confirm it can ship into your state.
3. Check FDA's annual reporting database. Search FDA's wholesale distributor and 3PL reporting database to see whether the distributor has submitted its annual report. FDA notes that appearing in the database does not by itself mean a facility is licensed or compliant, so do both checks.
4. Confirm the product is US-approved. For fillers, use FDA's list of approved dermal fillers and the PMA database it links to. For toxins, confirm the exact brand name, strength and labeling match the US product.
5. Ask for documentation. A legitimate distributor can give you invoices with product, lot and quantity details, and transaction information for prescription drugs. Be wary of suppliers who can't or won't.
6. Record what you verified. Keep a dated note of each check in your vendor file. If a regulator or manufacturer ever asks, you want to show a process, not a memory.

Red flags in supplier offers#

How do you inspect Botox and fillers when they arrive?#

Build authenticity checks into receiving, not into the treatment room. Whoever opens the box should run this checklist before anything goes into the refrigerator or onto a shelf.

Receiving checklist for any toxin or filler#

• The shipment came from a supplier on your approved vendor list, and the invoice matches your purchase order.
• Outer packaging and tamper-evident seals are intact.
• Refrigerated products arrived cold, in appropriate cold-chain packaging, per the product's label.
• All labeling is in English and matches the US product name, strength and manufacturer.
• Lot number and expiration date are present on both the carton and the vial or syringe, and they match each other.
• The product is not expired and has enough dating left for your expected usage.
• For fillers, the product is on FDA's approved list, and any patient record labels described in the instructions for use are present. For example, Restylane Lyft's instructions describe peel-off patient record labels intended for the patient's chart.
• Lot, expiration, quantity, supplier and receiving date are recorded in your inventory log (see our inventory and cold chain guide).

Botox-specific authentication features#

FDA and Allergan Aesthetics have published these identifiers for the genuine product:

For other toxin and filler brands, ask your manufacturer representative for their current authentication guide. Counterfeiters change tactics, so an inspection checklist is a backstop to sourcing discipline, never a substitute for it.

What should you do if you suspect counterfeit product?#

Speed matters, and so does documentation. Use this sequence:

1. Stop and quarantine. Don't use the product. Move it to a separate, clearly labeled "DO NOT USE: SUSPECT PRODUCT" area, keeping refrigerated items refrigerated so they can be tested if needed.
2. Document everything. Photograph the carton, vial or syringe, lot and expiration details, seals and shipping materials. Keep the packing slip, invoice and any supplier communications.
3. Check what else you received. Pull your inventory log for other units from the same supplier, order or lot, and check whether any were already used.
4. Contact the manufacturer. Manufacturers can confirm whether a lot number is real and whether it was distributed to your supplier.
5. Report to FDA. FDA's counterfeit alerts direct reports to 800-551-3989 or DrugSupplyChainIntegrity@fda.hhs.gov. For prescription drugs, once you determine a product is illegitimate, DSCSA requires notification to FDA and relevant trading partners within 24 hours via Form FDA 3911. Report suspected adverse events through FDA's MedWatch program.
6. Involve your medical director. Decide whether patients who may have received product from the same source need outreach or follow-up. That's a clinical and legal decision; loop in your medical director and healthcare attorney.
7. Suspend the supplier. Remove the supplier from your approved list until the investigation is complete.

How do you build an authorized-supply policy for your practice?#

A one-page written policy turns good intentions into a repeatable process, and it's what you'll want to show a regulator, insurer or manufacturer. Here's a template you can adapt.

Authorized supply policy: [Practice name]

1. Approved vendors. Prescription drugs, injectables and fillers are purchased only from vendors on the approved vendor list. The list records each vendor's state license number, the date it was verified, and (for branded injectables) manufacturer confirmation of authorized status.
2. Who can order. Only [roles] may place injectable orders. Orders above [amount] require approval by [role].
3. Receiving. Every toxin and filler delivery is inspected using the receiving checklist before it's stored. Lot, expiration, quantity and supplier are logged at receipt.
4. Storage. Products are stored according to the current manufacturer label. Refrigerator temperatures are monitored and logged.
5. Suspect product. Any suspect product is quarantined and escalated to [role] the same day. [Role] handles manufacturer, FDA and trading-partner notifications.
6. Review. The approved vendor list and this policy are reviewed at least annually and after any incident.

Two tips from practices that run this well: keep the approved vendor list short, and make the policy the default in your purchasing workflow so staff don't need to remember it. That's where purchase approvals and saved reorder lists help. Staff reorder from a list that only contains vetted products and suppliers.

How does Pink Kiwi approach authorized supply?#

Pink Kiwi is a wholesale marketplace where aesthetic practices compare offers from verified suppliers (distributors and manufacturer-direct) and buy in one checkout. On the compliance side:

• Suppliers are verified before they can list offers.
• Buyers are verified too. Practices verify their credentials before wholesale offers on restricted products become available.
• Checkout is gated. Prescription, DEA-scheduled and cold-chain items are gated at checkout based on the practice's verified credentials and the product's requirements.
• Spend controls such as purchase approvals, monthly budgets and saved reorder lists help keep ordering inside your approved list.

No marketplace should ask you to take authenticity on faith, including us. Use the verification steps above on any source you buy from, and ask each supplier the same questions.

If you're sourcing toxins and fillers for a new or growing injectables practice, our injectables page shows the product categories and supplier options available.

Key takeaways#

• Counterfeit and unapproved Botox has reached US medical practices repeatedly since at least 2012, almost always through unlicensed or unauthorized suppliers.
• Under the DSCSA, practices that administer prescription drugs must buy them from authorized trading partners. Verify licenses with the state and FDA, and confirm authorization with the manufacturer.
• Fillers are devices, not DSCSA-covered drugs. FDA still warns against buying them online and flags Juvederm Ultra 2, 3 and 4 as not approved for US use.
• Inspect every delivery: English labeling, correct names and strengths, matching lot and expiration on carton and vial, intact seals, and cold-chain condition.
• If something looks wrong, quarantine it, document it, call the manufacturer and report to FDA. For prescription drugs, the DSCSA clock is 24 hours from your determination.
• The legitimate way to beat gray-market pricing is to cut costs through authorized channels. See our buying guide, the injectable cold-chain storage article, and our upcoming whitepaper on authorized supply chain and traceability. You can also check your current toxin pricing against live offers with the rate-my-pricing tool.